ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Insulin Infusion in the Hospital Wards

This study has been completed.

Sponsored by: Emory University
Information provided by: Emory University
ClinicalTrials.gov Identifier: NCT00412347
  Purpose

Increasing evidence from clinical studies in Intensive Care Unit (ICU) settings indicates that insulin infusion can improve outcome measures for patients with hyperglycemia (high blood sugar) independent of a previous diagnosis of diabetes mellitus. This improvement in health could also apply to patients that have high blood sugars in various other non-critical care areas of the hospital as well. However, the data that shows improvement in health outcomes has been collected from wards that have a lower patient to provider and patient to nurse ratio, resulting in the ability for a much tighter control of the insulin infusion. We hypothesize that tight blood glucose control will provide the same benefits for patients in non-intensive care units settings but that these protocols may lead to a higher incidence of hypoglycemia (low blood sugar) and potentially to adverse outcomes in patients.

This study aims to determine the clinical outcome of patients treated with insulin infusion as well as the rate of hypoglycemic episodes in non-intensive areas. We will conduct a chart review of patients treated with insulin infusions in non-critical wards at Emory University Hospital during the period of 7/1/04 to 6/30/05. Medical records of all patients treated with intravenous insulin infusion protocols will be analyzed. Data on demographics, laboratory values, mortality rate, rate of hypoglycemic events, length of stay, as well as disposition at discharge will be analyzed.


Condition Intervention
Hyperglycemia
Drug: Insulin Drip Therapy

MedlinePlus related topics:   Hypoglycemia   

ChemIDplus related topics:   Insulin   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Retrospective
Official Title:   Insulin Infusion and Outcomes for Non-Critical Wards

Further study details as provided by Emory University:

Estimated Enrollment:   200
Study Start Date:   August 2006
Estimated Study Completion Date:   December 2006

  Eligibility
Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • All subjects over 18 years of age that received intravenous insulin treatment on general medical and surgical wards at Emory University Hospital during the period of 7/1/2004 to 6/30/2005
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00412347

Locations
United States, Georgia
University Hospital    
      Atlanta, Georgia, United States, 30324

Sponsors and Collaborators
Emory University

Investigators
Principal Investigator:     Guillermo Umpierrez, MD     Emory University    
  More Information


Study ID Numbers:   1203-2005
First Received:   December 14, 2006
Last Updated:   September 10, 2008
ClinicalTrials.gov Identifier:   NCT00412347
Health Authority:   United States: Institutional Review Board

Keywords provided by Emory University:
hyperglycemia  
diabetes  
insulin drip  
hypoglycemia  
general wards  

Study placed in the following topic categories:
Metabolic Diseases
Hyperglycemia
Diabetes Mellitus
Metabolic disorder
Glucose Metabolism Disorders
Hypoglycemia
Insulin

Additional relevant MeSH terms:
Hypoglycemic Agents
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on September 19, 2008




Links to all studies - primarily for crawlers